347
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Overdose Risk and Acquiring Opioids for Nonmedical Use Exclusively from Physicians in Vancouver, Canada

, , , , ORCID Icon, ORCID Icon & show all

References

  • Alexander, G. C., and Gielen A. C. eds. (2015). The prescription opioid epidemic: An evidence-based approach. Baltimore, USA.
  • Becker, W. C., Tobin, D. G., & Fiellin, D. A. (2011). Nonmedical use of opioid analgesics obtained directly from physicians: Prevalence and correlates. Archives of Internal Medicine, 171(11), 1034–1036. https://doi.org/10.1001/archinternmed.2011.217
  • British Columbia Coroners Service (2017). Fentanyl-detected illicit drug overdose deaths. January 1, 2012 to August 31, 2017. Burnaby, BC.
  • Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J., Agoritsas, T., Akl, E. A., Carrasco-Labra, A., Cooper, L., Cull, C., da Costa, B. R., Frank, J. W., Grant, G., Iorio, A., Persaud, N., Stern, S., Tugwell, P., Vandvik, P. O., & Guyatt, G. H. (2017). Guideline for opioid therapy and chronic noncancer pain. CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne, 189(18), E659–E666. https://doi.org/10.1503/cmaj.170363
  • Caudarella, A., Dong, H., Milloy, M., Kerr, T., Wood, E., & Hayashi, K. (2016). Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug and Alcohol Dependence, 162, 51–55. https://doi.org/10.1016/j.drugalcdep.2016.02.024
  • Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253–263. https://doi.org/10.1016/S0376-8716(98)00028-3
  • Darke, S., Mills, K. L., Ross, J., & Teesson, M. (2011). Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug and Alcohol Dependence, 115(3), 190–195. https://doi.org/10.1016/j.drugalcdep.2010.10.021
  • Darke, S., Ross, J., & Hall, W. (1996). Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction (Abingdon, England), 91(3), 413–417. https://doi.org/10.1046/j.1360-0443.1996.91341310.x
  • Dassieu, L., Kaboré, J.-L., Choinière, M., Arruda, N., & Roy, É. (2019). Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis. The International Journal on Drug Policy, 71, 150–156. https://doi.org/10.1016/j.drugpo.2019.03.023
  • Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet, 379(9810), 55–70. https://doi.org/10.1016/S0140-6736(11)61138-0
  • DeMatteo, D., Major, C., Block, B., Coates, R., Fearon, M., Goldberg, E., King, S. M., Millson, M., O'Shaughnessy, M., & Read, S. E. (1999). Toronto street youth and HIV/AIDS: Prevalence, demographics, and risks. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 25(5), 358–366. https://doi.org/10.1016/S1054-139X(99)00059-2
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic Pain-United States, 2016. JAMA, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464
  • Fischer, B., Gooch, J., Goldman, B., Kurdyak, P., & Rehm, J. (2014). Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: An update 5 years later. Canadian Journal of Public Health = Revue Canadienne de Sante Publique, 105(2), e146. https://doi.org/10.17269/cjph.105.4143
  • Ford, J. A., & Lacerenza, C. (2011). The relationship between source of diversion and prescription drug misuse, abuse, and dependence. Substance Use & Misuse, 46(6), 819–827. https://doi.org/10.3109/10826084.2010.538461
  • Gagajewski, A., & Apple, F. S. (2003). Methadone-related deaths in Hennepin County, Minnesota: 1992-2002. Journal of Forensic Sciences, 48(3), 668–671. https://doi.org/10.1520/JFS2002424
  • Hall, A. J., Logan, J. E., Toblin, R. L., Kaplan, J. A., Kraner, J. C., Bixler, D., Crosby, A. E., & Paulozzi, L. J. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613–2620. https://doi.org/10.1001/jama.2008.802
  • Han, H., Kass, P. H., Wilsey, B. L., & Li, C. S. (2014). Increasing trends in Schedule II opioid use and doctor shopping during 1999-2007 in California. Pharmacoepidemiology and Drug Safety, 23(1), 26–35. https://doi.org/10.1002/pds.3496
  • Jafari, S., Buxton, J. A., & Joe, R. (2015). Rising fentanyl-related overdose deaths in British Columbia. Canadian Journal of Addiction, 6(1), 4–6.
  • Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936. https://doi.org/10.1093/oxfordjournals.aje.a116813
  • Marshall, B. D. (2008). The contextual determinants of sexually transmissible infections among street-involved youth in North America. Culture, Health & Sexuality, 10(8), 787–799. https://doi.org/10.1080/13691050802295719
  • Miller, C. L., Kerr, T., Frankish, J. C., Spittal, P. M., Li, K., Schechter, M. T., & Wood, E. (2006). Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. Substance Use & Misuse, 41(2), 199–210. https://doi.org/10.1080/10826080500391795
  • National Advisory Committee on Prescription Drug Misuse. (2013). First do no harm: Responding to Canada’s prescription drug crisis. Ottawa.
  • Nolan, S., DeBeck, K., Nguyen, P., Kerr, T., & Wood, E. (2014). Binge drug use among street-involved youth in a Canadian setting. Addiction Research & Theory, 22(6), 535–540. https://doi.org/10.3109/16066359.2014.926896
  • Ontario Agency for Health Protection and Promotion (Public Health Ontario), & Leece, P. (2017). Evidence brief: Mortality following non-fatal opioid overdose. Toronto, Canada.
  • Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., Harvey, W., & Loring, L. D. (2012). A history of being prescribed controlled substances and risk of drug overdose death. Pain Medicine (Malden, Mass.), 13(1), 87–95. https://doi.org/10.1111/j.1526-4637.2011.01260.x
  • Pitt, A. L., Humphreys, K., & Brandeau, M. L. (2018). Modeling health benefits and harms of public policy responses to the US opioid epidemic. American Journal of Public Health, 108(10), 1394–1400. https://doi.org/10.2105/AJPH.2018.304590
  • Rothman, K., & Greenland, S. (1998). Modern epidemiology. Lippincott.
  • Rothstein, M. A. (2017). The opioid crisis and the need for compassion in pain management. American Journal of Public Health, 107(8), 1253–1254. https://doi.org/10.2105/ajph.2017.303906
  • Roxburgh, A., Burns, L., Drummer, O. H., Pilgrim, J., Farrell, M., & Degenhardt, L. (2013). Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug and Alcohol Review, 32(3), 269–275. https://doi.org/10.1111/dar.12033
  • Roy, É., Haley, N., Leclerc, P., Sochanski, B., Boudreau, J., & Boivin, J. (2004). Mortality in a cohort of street youth in Montreal. JAMA, 292(5), 569–574. https://doi.org/10.1001/jama.292.5.569
  • Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths—United States, 2000–2014. American Journal of Transplantation, 16(4), 1323–1327. https://doi.org/10.1111/ajt.13776
  • Voon, P., Callon, C., Nguyen, P., Dobrer, S., Montaner, J. S., Wood, E., & Kerr, T. (2015). Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug and Alcohol Review, 34(2), 221–228. https://doi.org/10.1111/dar.12226
  • Woo, A. (2018). Study finds prescription opioids not a significant driver of B.C. overdose crisis. The Globe and Mail. https://www.theglobeandmail.com/canada/british-columbia/article-study-finds-prescription-opioids-not-a-significant-driver-of-bc/
  • Wood, E., Stoltz, J.-A., Montaner, J., & Kerr, T. (2006). Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study. Harm Reduction Journal, 3(1), 18. https://doi.org/10.1186/1477-7517-7-5
  • Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S. G., O'Shaughnessy, M. V., & Schechter, M. T. (2002). Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (London, England)), 16(6), 941–943. https://doi.org/10.1097/00002030-200204120-00021
  • Yarborough, B. J. H., Stumbo, S. P., Janoff, S. L., Yarborough, M. T., McCarty, D., Chilcoat, H. D., Coplan, P. M., & Green, C. A. (2016). Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis. Drug and Alcohol Dependence, 167, 49–56. https://doi.org/10.1016/j.drugalcdep.2016.07.024

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.